ADC Therapeutics SA (ADCT)
4.125
+0.04
(+0.86%)
USD |
NYSE |
May 17, 16:00
4.125
0.00 (0.00%)
After-Hours: 20:00
ADC Therapeutics Total Long Term Debt (Quarterly): 113.23M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 113.23M |
| December 31, 2023 | 112.73M |
| September 30, 2023 | 112.04M |
| June 30, 2023 | 111.22M |
| March 31, 2023 | 110.54M |
| December 31, 2022 | 109.71M |
| September 30, 2022 | 109.20M |
| June 30, 2022 | 96.42M |
| March 31, 2022 | 94.96M |
| December 31, 2021 | 131.68M |
| Date | Value |
|---|---|
| September 30, 2021 | 92.45M |
| June 30, 2021 | 90.84M |
| March 31, 2021 | 39.37M |
| December 31, 2020 | 38.41M |
| September 30, 2020 | 36.43M |
| June 30, 2020 | 35.97M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
131.68M
Maximum
Dec 2021
71.76M
Average
93.71M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Roche Holding AG | 34.77B |
| Novartis AG | 25.53B |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | 0.00 |